Two rhenium compounds with benzimidazole ligands: synthesis and DNA interactions

Nataliia Shtemenko,Cristina Galiana-Rosello,Ariadna Gil-Martínez,Salvador Blasco,Jorge Gonzalez-García,Helen Velichko,Oleksandr Holichenko,Olexandr Shtemenko,Enrique García-España
DOI: https://doi.org/10.1039/d4ra02669a
IF: 4.036
2024-06-21
RSC Advances
Abstract:Two rhenium compounds: cis -tetrachlorotetrabenzimidazoldirhenium( III ) chloride – I and tetrabenzimidazoldioxorhenium( V ) – II have been synthesized and characterized. X-ray data are presented for the new complex II . I and II show strong emission that has been used to investigate their interaction with several non-canonical DNA structures. Both compounds have a quenching effect on the fluorescence intensity upon addition of the investigated oligonucleotides; I was more selective for binding G4-than II . Association constant values obtained for I and II with G-quadruplexes reached 10 6 M −1 , which suggests a strong interaction between both complexes and these sequences. FRET-melting assays show that I and II have a rather high level of stabilization of ckit1 and ckit2 quadruplexes. I is toxic against macrophages RAW267.7 only in high concentrations, while complex II shows no toxicity against these cells. I and II accumulate inside cells in different degrees. Molecular dynamic simulation studies have provided insights into the binding modes of II with ckit1 and ckit2 G-quadruplexes. The results obtained show the DNA binding activity of the rhenium complexes and their ability to be players in the anti-cancer fight since they can bind to non-canonical DNA forms in oncogene promoters, accumulate in some cancer cells, and influence the cancer cells microenvironment.
chemistry, multidisciplinary
What problem does this paper attempt to address?